Diabetes Mellitus
Showing NaN - NaN of 47
Tachycardia, Diabetes, Cardiovascular Disease Trial in Worldwide (Subcutaneous Implantable Cardioverter Defibrillator)
Active, not recruiting
- Tachycardia
- +2 more
- Subcutaneous Implantable Cardioverter Defibrillator
-
Huntsville, Alabama
- +48 more
Jan 26, 2023
Rare and Atypical Diabetes Network
Recruiting
- Diabetes Mellitus
- +6 more
-
Aurora, Colorado
- +13 more
Sep 14, 2022
Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-149 dose level 1, THR-149 dose level 2, THR-149
Recruiting
- Diabetes Mellitus
- +2 more
- THR-149 dose level 1
- +6 more
-
Beverly Hills, California
- +60 more
Aug 9, 2022
Diabetes, Hemodialysis Complication, Cardiovascular Complication Trial in Houston, Doha (Tennant Biomodulator ®)
Recruiting
- Diabetes Mellitus
- +3 more
- Tennant Biomodulator ®
-
Houston, Texas
- +1 more
Jun 2, 2022
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Eversense® CGM system)
Active, not recruiting
- Diabetes Mellitus
- +2 more
- Eversense® CGM system
-
Newport Beach, California
- +16 more
Mar 31, 2022
Hyperglycemia, Diabetes, Pancreas Ductal Adenocarcinoma Trial in Pasadena, Houston (Enriching New-onset Diabetes for Pancreatic
Recruiting
- Hyperglycemia
- +2 more
- Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score
- Abdominal imaging
-
Pasadena, California
- +1 more
Mar 29, 2022
Alveolar Bone Changes in Diabetes (ABCD) Study
Completed
- Diabetes Mellitus
- Well-controlled diabetic (WC)
- Poorly controlled diabetics (PC)
-
Minneapolis, Minnesota
- +2 more
Mar 1, 2022
Gastroparesis, Diabetes Trial in Worldwide (Placebo, Relamorelin)
Terminated
- Gastroparesis
- Diabetes Mellitus
- Placebo
- Relamorelin
-
Athens, Alabama
- +336 more
Nov 24, 2021
Gastroparesis, Diabetes Trial in Worldwide (Placebo, Relamorelin)
Terminated
- Gastroparesis
- Diabetes Mellitus
- Placebo
- Relamorelin
-
Anniston, Alabama
- +348 more
Nov 19, 2021
Gastroparesis, Diabetes Trial in Worldwide (Placebo, Relamorelin)
Terminated
- Gastroparesis
- Diabetes Mellitus
- Placebo
- Relamorelin
-
Athens, Alabama
- +239 more
Jul 15, 2021
Gastroparesis, Diabetes Trial in Worldwide (Placebo, Relamorelin)
Terminated
- Gastroparesis
- Diabetes Mellitus
- Placebo
- Relamorelin
-
Birmingham, Alabama
- +215 more
Jul 8, 2021
Arterio-Venous Fistula, ESRD, Steal Syndrome Trial in United States (VasQ)
Active, not recruiting
- Arterio-Venous Fistula
- +7 more
- VasQ
-
Birmingham, Alabama
- +14 more
Apr 11, 2021
Diabetes, Aging, Overweight Trial in Houston (Weight loss and Exercise, Healthy lifestyle)
Completed
- Diabetes Mellitus
- +2 more
- Weight loss and Exercise
- Healthy lifestyle
-
Houston, TexasMichael E DeBakey VA Medical Center
Jan 13, 2021
Diabetes Trial in United States (CLBS03 Low Dose, CLBS03 High Dose, Placebo)
Completed
- Diabetes Mellitus
- CLBS03 Low Dose
- +2 more
-
San Diego, California
- +14 more
Dec 14, 2020
Diabetes Trial in United States (Testing and Monitoring of Blood Glucose Levels, Primary care coordination, Diabetes-appropriate
Completed
- Diabetes Mellitus
- Testing and Monitoring of Blood Glucose Levels
- +3 more
-
Oakland, California
- +3 more
May 14, 2020
Diabetes, Asthma, Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Human Insulin Inhalation Powder, injected insulin)
Completed
- Diabetes Mellitus
- +2 more
- Human Insulin Inhalation Powder
- injected insulin
-
Montgomery, Alabama
- +100 more
Sep 9, 2019
Diabetes, Diabetes Complications, Gastroparesis Trial in Worldwide (Relamorelin, Placebo)
Diabetes Trial in Chicago, Hines, Houston (Empowering Patients in Chronic Care (EPIC), Enhanced Usual Care (EUC))
Completed
- Diabetes Mellitus
- Empowering Patients in Chronic Care (EPIC)
- Enhanced Usual Care (EUC)
-
Chicago, Illinois
- +2 more
Mar 19, 2019
Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in United States (THR-149 dose level 1, THR-149 dose level 2,
Completed
- Diabetes Mellitus
- +2 more
- THR-149 dose level 1
- +2 more
-
Phoenix, Arizona
- +6 more
Jun 12, 2019
Diabetes, Diabetic Macular Edema Trial in United States (ASP8232, ranibizumab, Placebo)
Completed
- Diabetes Mellitus
- Diabetic Macular Edema
- ASP8232
- +3 more
-
Phoenix, Arizona
- +20 more
Mar 4, 2019
Diabetes Trial in Worldwide (Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching )
Completed
- Diabetes Mellitus
- Albiglutide 30 mg
- +2 more
-
Birmingham, Alabama
- +607 more
Feb 11, 2019
Diabetes Trial in Worldwide (Exenatide, Exenatide matching )
Completed
- Diabetes Mellitus
- Exenatide
- Exenatide matching placebo
-
Birmingham, Alabama
- +122 more
Dec 17, 2018
Diabetes Trial in Worldwide (Exantide with Dapagliflozin, Exentide, Dapagliflozin)
Completed
- Diabetes Mellitus
- Exantide with Dapagliflozin
- +2 more
-
Birmingham, Alabama
- +133 more
Dec 6, 2018